BIOL

Biolase, Inc.
BIOL

Overview Fund Activity
Delisted

BIOL was delisted on the 18th of June, 2024.

Back to rankings

37 hedge funds and large institutions have $6.17M invested in Biolase, Inc. in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 13 increasing their positions, 5 reducing their positions, and 16 closing their positions.

Holders
37
Holders Change
-13
Holders Change %
-26%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
13
Reduced
5
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$70K
2
Commonwealth Equity Services
2
Commonwealth Equity Services
Massachusetts
$35K
3
EIM
3
Essex Investment Management
Massachusetts
$573K
4
Jane Street
4
Jane Street
New York
$10K
5
Renaissance Technologies
5
Renaissance Technologies
New York
$22K

Top Sellers

1
Acadian Asset Management
1
Acadian Asset Management
Massachusetts
$0
2
Marshall Wace
2
Marshall Wace
United Kingdom
$0
3
Charles Schwab
3
Charles Schwab
California
$0
4
VCM
4
Virtue Capital Management
Tennessee
$0
5
HF
5
HRT Financial
New York
$4K
Name Market Value Shares Shares
Change 		Shares
Change %
FMP
51
Financial Management Professionals
Texas
$0 325 – –
HNB
52
Huntington National Bank
Ohio
$0 1 – –
Wells Fargo
53
Wells Fargo
California
$0 943 +3 +0.3%
1 2
3